Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix

Cancer

Volumn 85, Issue 8, 1999, Pages 1799-1809

  Kokawa, Katsuji ^a   Shikone, Toshihiko ^a   Otani, Tsutomu ^a   Nakano, Ryosuke ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Apoptosis; Bax; Bcl 2; Squamous cell carcinoma; Uterine cervix

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; QUANTITATIVE DIAGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DNA FRAGMENTATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; UTERINE CERVICAL NEOPLASMS;

EID: 0033561010     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1799::AID-CNCR21>3.0.CO;2-M     Document Type: Article

References (46)

1. DiSaia PJ, Creasman WT. Clinical gynecologic oncology. 5th edition. St.Louis, MO: Mosby-Year Book, Inc., 1997:51-106.
2. Parker MF, Arroyo GF, Geradts J, Sabichi AL, Park RC, Taylor RR, et al. Molecular characterization of adenocarcinoma of the cervix. Gynecol Oncol 1997;64:242-51.
3. Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 1995;85:1017-21.
4. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31-41.
5. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
6. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991;65:1097-8.
7. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-400.
8. Nakano R. Apoptosis: gene-directed cell death. Horm Res 1997;48(Suppl 3):2-4.
9. ++-dependent endonuclease activity in rat granulosa and luteal cells. Endocrinology 1989;125:2218-20.
10. Arends MJ, Morris RG, Wyllie AH. Apoptosis: the role of the endonuclease. Am J Pathol 1990;136:593-608.
11. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
12. Tilly JL, Hsueh AJW. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J Cell Physiol 1993;154:519-26.
13. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
14. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994;73:2013-26.
15. Shikone T, Yamoto M, Kokawa K, Yamasnita K, Nishimori K, Nakano R. Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. J Clin Endocrinol Metabol 1996;81:2376-80.
16. Shikone T, Kokawa K, Yamoto M, Nakano R. Apoptosis of human ovary and uterine endometrium during the menstrual cycle. Horm Res 1997;48(Suppl 3):27-34.
17. Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metabol 1996;81:4144-7.
18. Kokawa K, Shikone T, Nakano R. Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta 1998;19:21-6.
19. Kokawa K, Shikone T, Nakano R. Apoptosis in human chorionic villi and decidua in normal and ectopic pregnancy. Mol Hum Reprod 1998;4:87-91.
20. Levine EL, Davidson SE, Roberts SA, Chadwick CA, Potten CS, West CML Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet 1994;344:472.
21. Sheets EE, Crum CP, Yeh J. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling. Gynecol Oncol 1996;63:94-100.
22. Shoji Y, Saegusa T, Takano Y, Ohbu M, Okayasu I. Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma. J Clin Pathol 1996;49:134-8.
23. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986; 83:5214-8.
24. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
25. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
26. Saegusa M, Takano Y, Hashimura M, Shoji Y, Okayasu I. The possible role of Bcl-2 expression in the progression of tumors of the uterine cervix. Cancer 1995;76:2297-303.
27. Rock JA, Thompson JD. Cancer of the cervix. In: Shingleton HM, Thompson JD, editors. Te Linde's operative gynecology. 8th edition. Philadelphia: Lippincott-Raven Publishers, 1997:1413-99.
28. Nakano R. Abdominal radical hysterectomy and bilateral pelvic lymph node dissections for caner of the cervix: the Okabayashi operation and its modifications. Gynecol Obstet Invest 1981;12:281-93.
29. Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Management of specific malignancies. Cervix, vagina, and vulva. In: Farias-Eisner R, Shapter AP, Casey AC, Berek JS, Walker DL, editors. Clinical oncology. Volume 5. Part III. New York: Churchill Livingstone, 1997:1527-67.
30. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-8.
31. Tao XJ, Tilly KI, Maravei DV, Shifren JL, Krajewski S, Reed JC, et al. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of box. J Clin Endocrinol Metabol 1997; 82:2738-46.
32. Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G, et al. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer 1995;75:522-9.
33. Leoncini L, Del Vecchio MT, Megha T, Barbini P, Galieni P, Pileri S, et al. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 1993;142;755-63.
34. McCluggage WG, Maxwell P, McBride HA, Hamilton PW, Bharucha H. Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol 1995;14:209-16.
35. Garcia I, Martinou I, Tsujimoto Y, Martintou J-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992;258:302-4.
36. McCluggage G, McBride H, Maxwell P, Bharucha H. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions. Int J Gynecol Pathol 1997;16:22-7.
37. Nakamura T, Nomura S, Sakai T, Nariya S. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions. Hum Pathol 1997;28: 309-15.
38. long messenger ribonucleic acid levels. Endocrinology 1995;136:232-41.
39. Rueda BR, Tilly KI, Botros IW, Jolly PD, Hansen TR, Hoyer PB, et al. Increased bax and interleukin-1β-converting enzyme messenger ribonucleic acid levels coincide with apoptosis in the bovine corpus luteum during structural regression. Biol Reprod 1997;56:186-93.
40. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
41. Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer 1996;77:2275-9.
42. Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Gynecol Oncol 1997;65:23-9.
43. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 1990; 63:1129-36.
44. Lane DP. p53, guardian of the genome. Nature 1992;358: 15-6.
45. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-805.
46. Cipl/WAFI/Sdit. J Pathol 1997;183:134-40.